Publications
13 January 2024

The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum

Lancet. 2024 Jan 13;403(10422):124-126. doi: 10.1016/S0140-6736(23)02798-8. Epub 2023 Dec 18. PMID: 38128557. The future of the global clinical trial ecosystem: a vision from the first WHO […]
16 January 2024

Advances in tissue engineering and 3D bioprinting for corneal regeneration

 IJB null, 0(0), 1669. https://doi.org/10.36922/ijb.1669 Advances in tissue engineering and 3D bioprinting for corneal regeneration Authors: Tamás Monostori1,2,3, Diána Szűcs1,2,3, Borbála Lovászi1,2,3, Lajos Kemény3,4, Zoltán Veréb1,3* Affiliation: Abstract: Blindness resulting from […]
16 January 2024

Gamma-secretase inhibitors down-regulate the pro-fibrotic Notch signaling pathway in recessive dystrophic epidermolysis bullosa

J Invest Dermatol. 2024 Jan 16:S0022-202X(24)00001-0. doi: 10.1016/j.jid.2023.10.045. Epub ahead of print. PMID: 38237731. Gamma-secretase inhibitors down-regulate the pro-fibrotic Notch signaling pathway in recessive dystrophic epidermolysis […]
17 January 2024

Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care

 Cells. 2024 Jan 17;13(2):179. doi: 10.3390/cells13020179. PMID: 38247870; PMCID: PMC10814238. Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care Authors: Francisco […]
20 January 2024

CRISPR technology: A decade of genome editing is only the beginning

Science. 2023 Jan 20;379(6629):eadd8643. doi: 10.1126/science.add8643. Epub 2023 Jan 20. PMID: 36656942. CRISPR technology: A decade of genome editing is only the beginning Authors: Joy Y […]
27 January 2024

Animal Models for Limbal Stem Cell Deficiency: A Critical Narrative Literature Review

Ophthalmol Ther. 2024 Jan 27. doi: 10.1007/s40123-023-00880-0. Epub ahead of print. PMID: 38280103. Animal Models for Limbal Stem Cell Deficiency: A Critical Narrative Literature Review Authors: […]
31 January 2024

Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa

JAMA Dermatol. 2024 Jan 31. doi: 10.1001/jamadermatol.2023.5857. Epub ahead of print. PMID: 38294784; PMCID: PMC10831624. Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa Authors: Adam […]
3 February 2024

Impact of culture media on primary human corneal endothelial cells derived from old donors

 Exp Eye Res. 2024 Feb 3:109815. doi: 10.1016/j.exer.2024.109815. Epub ahead of print. PMID: 38316204. Impact of culture media on primary human corneal endothelial cells derived from […]
3 February 2024

US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation

Cytotherapy. 2024 Feb 3:S1465-3249(24)00020-3. doi: 10.1016/j.jcyt.2024.01.002. Epub ahead of print. PMID: 38310500. US state laws on medical freedom and investigational stem cell procedures: a call to […]